Skip to main content

Table 3 Associations between clinical variables and S-HPX

From: Increased sialylation of site specific O-glycoforms of hemopexin in liver disease

 

All (n = 46)

Fibrosis (n = 22)

Cirrhosis (n = 24)

rs

p value

rs

p value

rs

p value

Age

−0.034

0.832

0.160

0.489

0.017

0.945

Bilirubin (mg/dL)

0.409

0.008*

0.088

0.705

0.393

0.086

Creatinine (mg/dL)

−0.166

0.270

0.129

0.568

−0.363

0.081

INR

0.390

0.012*

0.039

0.866

0.006

0.979

MELD

0.279

0.061

0.215

0.338

0.134

0.534

AFP (ng/mL)

0.578

<0.001*

0.429

0.052

0.439

0.053

Albumin (g/dL)

−0.436

0.004*

−0.040

0.862

−0.511

0.021*

Alk. phosphastase (U/L)

0.195

0.193

0.116

0.608

0.185

0.387

ALT (U/L)

0.337

0.031*

−0.163

0.480

0.346

0.135

AST (U/L)

0.520

0.001*

−0.087

0.709

0.747

0.001*

Platelet (109/L)

−0.564

<0.001*

−0.462

0.035*

−0.358

0.121

FIB-4

0.612

<0.001*

0.366

0.103

0.574

0.008*

APRI

0.562

<0.001*

0.158

0.493

0.589

0.006*

  1. Spearman correlation coefficients were evaluated in all samples combined and in the fibrosis and cirrhosis groups, separately
  2. * Significance level <0.05
Back to article page

Clinical Proteomics

ISSN: 1559-0275